Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation
Background: The APEKS-cUTI study demonstrated the non-inferiority of cefiderocol to imipenem−cilastatin in the primary endpoint of the composite of clinical and microbiological outcome in patients with complicated urinary tract infections (cUTIs). We piloted a structured patient interview (SPI) to e...
Guardado en:
Autores principales: | Simon Portsmouth, Roger Echols, Kiichiro Toyoizumi, Glenn Tillotson, Tsutae Den Nagata |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3f3b4385cc24a1e89e68c28a8f0a782 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors for hospital readmission following complicated urinary tract infection
por: Tanya Babich, et al.
Publicado: (2021) -
Lower urinary tract symptoms
Publicado: (2009) -
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
por: Jacob E Choby, et al.
Publicado: (2021) -
Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
por: Haajira Beevi Habeeb Rahuman, et al.
Publicado: (2021) -
Cornus Mas and Urinary Tract Infections Treatment
por: Fatemeh Khatami, et al.
Publicado: (2020)